Skip to main content
. 2014 May 16;9(5):e97824. doi: 10.1371/journal.pone.0097824

Figure 5. Schematic Diagram of APN Therapeutic Potential in Treating T2DM-Associated Periodontitis.

Figure 5

We established experimental periodontitis in APN−/− and DIO mice and treated them with systemic APN infusion. Our results support the notion that systemic administration with APN may constitute a therapeutic strategy to ameliorate T2DM-associated periodontitis due to dual roles of APN at inhibiting osteoclastic activity and hence bone resorption, and at attenuating inflammation.